Login / Signup

Results from the prospective, multicenter AMBULATE-CAP trial: Reduced use of urinary catheters and protamine with hemostasis via the Mid-Bore Venous Vascular Closure System (VASCADE® MVP) following multi-access cardiac ablation procedures.

Amin Al-AhmadSuneet MittalDavid DeLurgioG Joseph GallinghouseRodney P HortonMark W PremingerJ David BurkhardtAndrea Natale
Published in: Journal of cardiovascular electrophysiology (2020)
The VVCS was effective for achieving hemostasis following catheter-based procedures; access site closure-related complications and adverse events were well managed.
Keyphrases
  • study protocol
  • clinical trial
  • phase iii
  • phase ii
  • cross sectional
  • heart failure
  • double blind
  • ultrasound guided
  • open label